AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.8249
-0.0051 (-0.61%)
At close: Nov 24, 2025, 4:00 PM EST
0.8105
-0.0144 (-1.75%)
After-hours: Nov 24, 2025, 4:10 PM EST
AEON Biopharma Market Cap
AEON Biopharma has a market cap or net worth of $9.6 million as of November 24, 2025. Its market cap has decreased by -72.28% in one year.
Market Cap
9.60M
Enterprise Value
21.75M
1-Year Change
-72.28%
Ranking
Category
Stock Price
$0.82
Market Cap Chart
Since April 12, 2021, AEON Biopharma's market cap has decreased from $63.66M to $9.60M, a decrease of -84.91%. That is a compound annual growth rate of -33.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 9.66M | -55.22% |
| Dec 31, 2024 | 21.58M | -91.93% |
| Dec 29, 2023 | 267.55M | -80.82% |
| Dec 30, 2022 | 1.40B | 553.24% |
| Dec 30, 2021 | 213.58M | 235.51% |
| Apr 12, 2021 | 63.66M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 948.84B |
| Johnson & Johnson | 491.26B |
| AbbVie | 417.60B |
| UnitedHealth Group | 289.84B |
| AstraZeneca | 280.49B |
| Novartis AG | 243.93B |
| Merck & Co. | 242.64B |
| Abbott Laboratories | 222.77B |